Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL J CONNOR

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1114924578
CMS profile
765375
Location
KANSAS CITY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$1,025.16

49 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,025.16 49

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL J CONNOR

NPI 1114924578 · CMS profile ID 765375

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

KANSAS CITY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1114924578?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL J CONNOR, NPI 1114924578, CMS profile ID 765375. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1114924578?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MICHAEL J CONNOR, NPI 1114924578, CMS profile ID 765375. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1114924578?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MICHAEL J CONNOR, NPI 1114924578, CMS profile ID 765375, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–49 of 49 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1114924578?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

49 matching records · $1,025.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 49 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–49 of 49.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celltrion USA Inc. $24.1712/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250820662 CMS
PFIZER INC. $19.3312/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229344351 CMS
Aimmune Therapeutics, Inc. $16.1311/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249689899 CMS
ABBVIE INC. $22.1511/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688675 CMS
Ipsen Biopharmaceuticals, Inc $22.6711/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208826367 CMS
Janssen Biotech, Inc. $22.5911/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174948109 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.7111/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231965744 CMS
PFIZER INC. $14.6010/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229854278 CMS
Ardelyx, Inc. $16.1410/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247842302 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.5410/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223870474 CMS
ABBVIE INC. $23.6110/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688673 CMS
PFIZER INC. $18.8310/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229965423 CMS
ABBVIE INC. $4.6410/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688671 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.6910/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223846246 CMS
ABBVIE INC. $24.7110/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688669 CMS
Ipsen Biopharmaceuticals, Inc $20.6509/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208826365 CMS
PFIZER INC. $17.7209/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229437112 CMS
ABBVIE INC. $16.9509/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688667 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.9108/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231965742 CMS
Janssen Biotech, Inc. $21.6808/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174952475 CMS
Madrigal Pharmaceuticals $27.0808/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248250544 CMS
ABBVIE INC. $19.8008/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688665 CMS
ABBVIE INC. $26.8108/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688663 CMS
Lilly USA, LLC $28.8308/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186838839 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.3908/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223877294 CMS
Lilly USA, LLC $21.1707/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186778261 CMS
Madrigal Pharmaceuticals $18.4507/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248250539 CMS
ABBVIE INC. $33.4207/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688661 CMS
ABBVIE INC. $20.5307/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688659 CMS
ABBVIE INC. $22.9805/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688657 CMS
ABBVIE INC. $23.2705/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688655 CMS
Lilly USA, LLC $26.5705/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186767950 CMS
ABBVIE INC. $17.9404/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688653 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.5004/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223853063 CMS
Regeneron Healthcare Solutions, Inc. $17.0703/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212894665 CMS
ABBVIE INC. $22.0903/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688651 CMS
Phathom Pharmaceuticals, Inc. $16.5803/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219307769 CMS
ABBVIE INC. $22.6403/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688649 CMS
Janssen Biotech, Inc. $35.0003/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174947624 CMS
ABBVIE INC. $16.6202/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688645 CMS
ABBVIE INC. $16.7002/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688647 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.6302/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223893463 CMS
Aimmune Therapeutics, Inc. $19.1402/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249689901 CMS
ABBVIE INC. $18.9601/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688643 CMS
Phathom Pharmaceuticals, Inc. $13.4701/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219307811 CMS
ABBVIE INC. $23.1001/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688641 CMS
ABBVIE INC. $9.3601/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201688639 CMS
Regeneron Healthcare Solutions, Inc. $20.1401/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212894663 CMS
Lilly USA, LLC $31.5001/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186754279 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $263.03 7
PY2020 $154.73 7
PY2021 $701.70 43
PY2022 $936.43 54
PY2023 $1,031.69 51
PY2024 $941.95 44
PY2025 $1,025.16 49

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $17,016.00 4
PY2022 Principal investigator $8,615.60 11
PY2021 Principal investigator $3,311.50 3
PY2020 Principal investigator $131,148.40 321
PY2019 Principal investigator $1,448.10 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $678.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168395
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $26.90 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168397
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $784.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168399
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $784.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168401
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $784.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168403
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $784.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168405
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $765.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168407
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $765.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168409
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $765.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168411
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $678.00 05/16/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
A PHASE 3B OPEN-LABEL STUDY TO DETERMINE THE LONG-TERM SAFETY AND EFFICACY OF VEDOLIZUMAB SUBCUTANEOUS IN SUBJECTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE No dispute reported 06/30/2026 937168413
Principal investigator 1 Roche Products Limited $1,801.70 03/25/2022 Non-covered Recipient Entity
EHRHARDT CLINICAL RESEARCH LLC
CROHN S DISEASE PROGRAM COHORT 1 INDUCTION COHORT II MAINTENANCE No dispute reported 06/30/2026 950752243